Abstract
It has been hypothesized that skin barrier function in early human life determines the onset of atopic dermatitis (AD) and atopic march. Finding early signs of skin abnormalities in newborns before the onset of AD may identify infants at risk to develop AD who can benefit from skin barrier enhancing therapies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
